title: Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
abstract: BACKGROUND
  In a double-blind crossover study we evaluated the antitremor effect of a 4-week treatment with either escalating dosages of levetiracetam or placebo in orthostatic tremor.
  
  
  METHODS
  Twelve patients with orthostatic tremor participated in the study. Primary end point was improvement in stance duration. Secondary end points were total track length of the sway path and tremor total power. The patients' impression of impairment was assessed by a visual analog scale and quality of life by the SF-36.
  
  
  RESULTS
  We found no significant effect of dosage or treatment on stance duration (P = .175), total track length (P = .690), total power (P = .280), or visual analog scale (P =.735). Neither was SF-36 differentially changed by levetiracetam or placebo (SF-36, Physical Component Summary: P = .079; SF-36, Mental Component Summary: P = .073). Side effects like dizziness, fatigue, or nausea were only mild to moderate.
  
  
  CONCLUSIONS
  Levetiracetam is ineffective in the treatment of orthostatic tremor.
authors.affiliation: Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
authors.forename: Helge
authors.initials: H
authors.lastname: Hellriegel
authors.forename: Jan
authors.initials: J
authors.lastname: Raethjen
authors.forename: G
authors.initials: G
authors.lastname: Deuschl
authors.forename: Jens
authors.initials: J
authors.lastname: Volkmann
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D018592:Cross-Over Studies; D004244:Dizziness / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D010919:Placebos; D016896:Treatment Outcome; D014202:Tremor / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000927:Anticonvulsants; D010919:Placebos; D000077287:Levetiracetam; D010889:Piracetam